Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 466,580 | |
| Option exercise | 20 | 331,460 | |
| Tax withholding / forfeiture | 10 | 71,262 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
51 Form 4 filings on record, the earliest from Oct 16, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel Gordon Kirby - Officer | Option exercise | Common Stock | 10,001 | $0.00 | - | |
| Daniel Gordon Kirby - Officer | Tax withholding / forfeiture | Common Stock | 2,436 | $6.40 | $16K | |
| Daniel Gordon Kirby - Officer | Option exercise | Restricted Stock Units | 10,001 | $0.00 | - | |
| Corleen M. Roche - Officer | Option exercise | Common Stock | 49,995 | $0.00 | - | |
| Corleen M. Roche - Officer | Tax withholding / forfeiture | Common Stock | 21,238 | $6.21 | $132K | |
| Corleen M. Roche - Officer | Option exercise | Restricted Stock Units | 49,995 | $0.00 | - | |
| Michael Weiser - Director | Grant or award | Deferred Restricted Stock Unit | 90,316 | $0.00 | - | |
| Iain D. Dukes - Director | Grant or award | Deferred Restricted Stock Unit | 180,632 | $0.00 | - | |
| Athena Countouriotis - Director | Grant or award | Deferred Restricted Stock Unit | 90,316 | $0.00 | - | |
| Ryan D. Maynard - Director | Grant or award | Deferred Restricted Stock Unit | 90,316 | $0.00 | - | |
| Raj K. Puri - Officer | Grant or award | Restricted Stock Units | 15,000 | $0.00 | - | |
| Option exercise | Common Stock | 15,625 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 6,638 | $4.23 | $28K | ||
| Option exercise | Restricted Stock Units | 15,625 | $0.00 | - | ||
| Option exercise | Common Stock | 7,813 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 3,976 | $4.23 | $17K | ||
| Option exercise | Restricted Stock Units | 7,813 | $0.00 | - | ||
| Raj K. Puri - Officer | Option exercise | Common Stock | 9,766 | $0.00 | - | |
| Raj K. Puri - Officer | Tax withholding / forfeiture | Common Stock | 3,843 | $4.23 | $16K | |
| Raj K. Puri - Officer | Option exercise | Restricted Stock Units | 9,766 | $0.00 | - | |
| Option exercise | Common Stock | 7,813 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 3,976 | $4.23 | $17K | ||
| Option exercise | Restricted Stock Units | 7,813 | $0.00 | - | ||
| Option exercise | Common Stock | 41,668 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 17,701 | $3.96 | $70K | ||
| Option exercise | Restricted Stock Units | 41,668 | $0.00 | - | ||
| Raj K. Puri - Officer | Option exercise | Common Stock | 5,469 | $0.00 | - | |
| Raj K. Puri - Officer | Tax withholding / forfeiture | Common Stock | 2,508 | $3.96 | $10K | |
| Raj K. Puri - Officer | Option exercise | Restricted Stock Units | 5,469 | $0.00 | - | |
| Option exercise | Common Stock | 8,790 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 4,473 | $3.96 | $18K | ||
| Option exercise | Restricted Stock Units | 8,790 | $0.00 | - | ||
| Option exercise | Common Stock | 8,790 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 4,473 | $3.96 | $18K | ||
| Option exercise | Restricted Stock Units | 8,790 | $0.00 | - | ||
| Daniel Gordon Kirby - Officer | Option exercise | Common Stock | 10,000 | $0.00 | - | |
| Daniel Gordon Kirby - Officer | Tax withholding / forfeiture | Common Stock | 2,435 | $3.70 | $9K | |
| Daniel Gordon Kirby - Officer | Option exercise | Restricted Stock Units | 10,000 | $0.00 | - | |
| Corleen M. Roche - Officer | Grant or award | Restricted Stock Units | 132,200 | $0.00 | - | |
| Grant or award | Restricted Stock Units | 235,000 | $0.00 | - | ||
| Raj K. Puri - Officer | Grant or award | Restricted Stock Units | 117,500 | $0.00 | - | |
| Grant or award | Restricted Stock Units | 58,750 | $0.00 | - | ||
| Daniel Gordon Kirby - Officer | Grant or award | Restricted Stock Units | 132,200 | $0.00 | - | |
| Grant or award | Restricted Stock Units | 117,500 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 26,755 | $4.58 | $123K | ||
| Option exercise | Restricted Stock Units | 62,493 | $0.00 | - | ||
| Option exercise | Common Stock | 62,493 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 31,246 | $0.00 | - | ||
| Option exercise | Common Stock | 31,246 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 16,520 | $4.58 | $76K | ||
| Raj K. Puri - Officer | Option exercise | Common Stock | 39,059 | $0.00 | - | |
| Raj K. Puri - Officer | Tax withholding / forfeiture | Common Stock | 18,360 | $4.58 | $84K | |
| Raj K. Puri - Officer | Option exercise | Restricted Stock Units | 39,059 | $0.00 | - | |
| Option exercise | Restricted Stock Units | 31,246 | $0.00 | - | ||
| Option exercise | Common Stock | 31,246 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 16,628 | $4.58 | $76K | ||
| Tax withholding / forfeiture | Common Stock | 22,809 | $3.79 | $86K | ||
| Option exercise | Restricted Stock Units | 41,669 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 10,418 | $0.00 | - | ||
| Option exercise | Common Stock | 52,087 | $0.00 | - | ||
| Option exercise | Common Stock | 12,307 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 6,903 | $3.79 | $26K | ||
| Option exercise | Restricted Stock Units | 8,790 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 3,517 | $0.00 | - | ||
| Raj K. Puri - Officer | Option exercise | Common Stock | 5,470 | $0.00 | - | |
| Raj K. Puri - Officer | Tax withholding / forfeiture | Common Stock | 2,798 | $3.79 | $11K | |
| Raj K. Puri - Officer | Option exercise | Restricted Stock Units | 5,470 | $0.00 | - | |
| Option exercise | Restricted Stock Units | 3,907 | $0.00 | - | ||
| Option exercise | Common Stock | 12,697 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 7,122 | $3.79 | $27K | ||
| Option exercise | Restricted Stock Units | 8,790 | $0.00 | - |
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had 15 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for IOVA runs to 51 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of IOVA were filed in the last 90 days.
No insider sales of IOVA were filed in the last 90 days. 1 sale is on record for this company.
This page tracks IOVA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IOVA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.